Rolls-Royce Grounds a Hydrogen Milestone as Geopolitical Headwinds Rattle Aviation Sentiment
Rolls-Royce has delivered a genuine technological breakthrough—successfully running a Pearl-15 engine on 100% hydrogen at full takeoff thrust—only to see...
Ocugen Halves Interest Expense as $130M Convertible Refinances High-Cost Debt
Ocugen has pulled off a financing manoeuvre that slashes its interest burden in half, using a $130 million convertible bond...
Palantir’s Record Quarter Meets a Wall of Worry: Yields, Valuation, and Insider Sales Eclipse a Ukraine Showcase
Palantir delivered its strongest financial quarter ever — revenue up 85% to $1.633 billion, net income surging to $870.5 million,...
Palantir’s Ukraine Showcase Can’t Shake the Stock’s Valuation Hangover
Alex Karp’s face-to-face with Volodymyr Zelenskyy in Kyiv on Tuesday was everything Palantir could want from a product demonstration: a...
Highland Critical Minerals Secures C$400,000 for Summer Fieldwork Amid CIRO Probe and 47% Share Price Rout
The Church property in northern Ontario is shaping up as the next inflection point for Highland Critical Minerals. The junior...
SoftBank Reports Historic ¥5 Trillion Profit, but a Funding Pullback Reveals Creeping Caution
When Masayoshi Son’s SoftBank Group unveils a net profit that dwarfs anything a Japanese company has ever delivered, the natural...
Aixtron’s Optoelectronics Pivot Fuels a Record Order Book, but the Profit Engine Still Needs Time
When Aixtron shareholders file into the company’s annual general meeting on May 13, the numbers on the table will tell...
Siemens Energy Posts €835 Million Quarterly Profit, Doubles Cash Flow Target as AI and Grid Expansion Fuel Record Orders
The turnaround at Siemens Energy is gathering pace. The industrial group reported a net profit of €835 million for its...
Overbought and Overexposed: The MSCI World ETF Navigates a New Fed and Pharma Tariffs
The iShares MSCI World ETF (URTH) closed at a fresh 52-week high of $200.64, but the reading of 94.6 on...
BioNTech’s Radical Overhaul: 1,860 Job Cuts, Factory Shutdowns, and a €532 Million Loss as Cancer Bet Takes Center Stage
The era of pandemic-era blockbuster revenues at BioNTech has come to a definitive end. The Mainz-based biotech is shuttering four...
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Walgreens Implements Deep Restructuring Following Private Buyout
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
